Heteroaryl Aminopropanol Derivatives As Inhibitors Of Lta4H - EP4323062
EP4323062
- Filing Date
- Apr 13, 2022
- Status
- Granted
- Grant Date
- Jul 23, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4323062B1 was granted to Novartis on Jul 23, 2025 following the initial filing on Apr 13, 2022 under the application number The current legal status of the patent is Granted.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents